Related Experiment Video

Updated: Oct 18, 2025

Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas
07:00

Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas

Published on: February 28, 2019

6.0K

Sox2 Is an Oncogenic Driver of Small-Cell Lung Cancer and Promotes the Classic Neuroendocrine Subtype

Ellen Voigt1,2, Madeline Wallenburg1,2, Hannah Wollenzien1,2,3

  • 1Cancer Biology and Immunotherapies Group, Sanford Research, Sioux Falls, South Dakota.

Molecular Cancer Research : MCR
|October 1, 2021
PubMed

Insights

SOX2 is essential for small-cell lung cancer (SCLC) development and progression. This study reveals SOX2’s role in regulating key SCLC pathways, offering new therapeutic targets for this challenging disease.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Small-cell lung cancer (SCLC) therapies have seen limited progress despite advances in other cancers.
  • RB1 loss is a key driver in SCLC, often correlating with increased SOX2 expression.
  • SOX2 is frequently amplified and highly expressed in SCLC, linked to tumor growth.

Purpose of the Study:

  • To investigate the role of SOX2 in SCLC initiation and progression.
  • To elucidate the molecular mechanisms by which SOX2 influences SCLC subtypes and pathways.
  • To identify SOX2 as a potential therapeutic target for SCLC.

Main Methods:

  • Utilized a genetically engineered mouse model to assess SOX2's necessity in SCLC formation.
  • Employed genome-scale binding assays to identify SOX2-regulated pathways.
  • Analyzed the association between SOX2 and SCLC subtype switching (ASCL1 to NEUROD1).

Main Results:

  • Demonstrated that SOX2 is required for efficient SCLC formation in a mouse model.
  • Identified SOX2 as a regulator of critical SCLC pathways, including NEUROD1 and MYC.
  • Showed SOX2's potential role in the subtype switch from ASCL1 to NEUROD1 in SCLC.

Conclusions:

  • SOX2 plays a crucial role in SCLC development and progression.
  • Understanding SOX2's regulatory functions is key to deciphering SCLC heterogeneity and treatment resistance.
  • Targeting SOX2 may offer novel therapeutic strategies for small-cell lung cancer.

More Related Videos

An Optimized Protocol for Electrophoretic Mobility Shift Assay Using Infrared Fluorescent Dye-labeled Oligonucleotides09:58

An Optimized Protocol for Electrophoretic Mobility Shift Assay Using Infrared Fluorescent Dye-labeled Oligonucleotides

Published on: November 29, 2016

16.1K
Author Spotlight: Establishing a Murine Non-Small Cell Lung Cancer Model for Developing Nanoformulations of Anticancer Drugs05:11

Author Spotlight: Establishing a Murine Non-Small Cell Lung Cancer Model for Developing Nanoformulations of Anticancer Drugs

Published on: May 10, 2024

1.3K

Related Concept Videos

Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
41.6K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
13.3K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.4K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.6K